Improving HIV prevention for patients with STIs after emergency department visits

Telephone Initiated PrEP Post-ED Discharge (TIPPED)

NIH-funded research Icahn School of Medicine at Mount Sinai · NIH-11087608

This study is working to make it easier for people with sexually transmitted infections to start taking HIV prevention medication after they visit the emergency room, by giving them helpful follow-up calls to encourage them to get the care they need.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11087608 on NIH RePORTER

What this research studies

This research focuses on enhancing HIV prevention care for individuals diagnosed with sexually transmitted infections (STIs) in emergency departments (EDs). The project aims to develop a protocol called Telephone Initiated PrEP Post-ED Discharge (TIPPED), which will facilitate the initiation of HIV pre-exposure prophylaxis (PrEP) for high-risk patients. By engaging patients through follow-up calls after their ED visit, the study will provide tailored counseling to encourage PrEP uptake and ensure ongoing care. The goal is to create a sustainable model for HIV prevention that leverages the unique position of EDs as access points for at-risk individuals.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with sexually transmitted infections who visit emergency departments and are at high risk for HIV.

Not a fit: Patients who are not at risk for HIV or do not have STIs may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly increase the number of individuals at high risk for HIV who start and maintain PrEP treatment.

How similar studies have performed: Previous research has shown that emergency departments can effectively serve as access points for HIV prevention, indicating potential success for this novel approach.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.